循環器内科 Twitter アカウントlanguage English

英文総説 "2005～2009" Review Papers in English


＞2009　＞2008　＞2007　＞2006　＞2005

緑色のタイトル部分をクリックすると、総説PDFが表示されます。

【 2009 年 】

  1. Shimokawa H, Heistad D. In memoriam: Akira Takeshita, MD, PhD. (1940-2009). Arterioscler Thromb Vasc Biol. 29;787-788,2009.

  2. Ito K, Fukumoto Y, Shimokawa H. Extracorporeal shock wave therapy as a new and non-invasive angiogenic strategy. Tohoku J Exp Med. 219:1-9,2009.

  3. Maseri A, Beltrame JF, Shimokawa H. Role of coronary vasoconstriction in ischemic heart disease and search for novel therapeutic target. Circ J. 73:394-403,2009.

  4. Tsutsui M, Shimokawa H, Otsuji Y, Ueta Y, Sasaguri Y, Yanagihara N. Nitric oxide synthases and cardiovascular diseases-Insights from genetically modified mice-. Circ J. 73:986-993,2009.

  5. Vanhoutte PM, Shimokawa H, Tang EHC, Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol. 196:193-222,2009.

  6. Yasuda S, Shimokawa H. Acute myocardial infarction-The enduring challenge for cardiac protection and survival-. Circ J. 73:2000-2008,2009.

【 2008 年 】

  1. Shiba N, Shimokawa H. Chronic heart failure in Japan: Implications of the CHART studies. Vascular Health and Risk Management. 4:103-113,2008.

  2. Shimokawa H, Ito K, Fukumoto Y, Yasuda S. Extracorporeal cardiac shock wave therapy for ischemic heart disease. Shock Wave. 17:449-455,2008.

  3. Shimokawa H, Yasuda S. Myocardial ischemia: current concepts and future perspectives. J Cardiol. 52:67-78,2008.

  4. Tsutsui M, Nakata S, Shimokawa H, Otsuji Y, Yanagihara N. Spontaneous myocardial infarction and nitric oxide synthase. JTrend Cardiovasc Sci. 18:275-279,2008.

【 2007 年 】

  1. Fukumoto Y, Tawara S, Shimokawa H. Recent progress in the treatment of pulmonary arterial hypertension -Expectation for Rho-kinase inhibitors-. Tohoku J Exp Med. 211:309-320,2007.

  2. Shimokawa H, Rashid M. Development of Rho-kinase inhibitors for cardiovascular medicine. Trends Pharmacol Sci. 28:296-302,2007.

【 2006 年 】

  1. Tsutsui M, Shimokawa H, Morishita T, Nakashima Y, Yanagihara N. Development of genetically engineered mice lacking all three nitric oxide synthases. J Pharmacol Sci. 102:147-154,2006.

【 2005 年 】

  1. Hirooka Y, Shimokawa H. Therapeutic potential of Rho-kinase inhibitors in cardiovascular diseases. Am J Cardiovasc Drugs. 5:31-39,2005.

  2. Komaru T, Shirato K. Myocardial ischemia and coronary microvascular vasomotion: The impact of hypercholesterolemia. Future Cardiol. 1:637-647,2005.

  3. Shimokawa H, Takeshita A. Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler Thromb Vasc Biol. 25:1767-1775,2005.

  4. Shimokawa H, Morikawa K. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in animals and humans. J Mol Cell Cardiol. 39:725-732,2005.